Literature DB >> 9380436

Effects of chronic prenatal hypoxia on tyrosine hydroxylase and phenylethanolamine N-methyltransferase messenger RNA and protein levels in medulla oblongata of postnatal rat.

L D White1, E E Lawson.   

Abstract

Catecholamines are a class of neurotransmitters involved in central nervous system autonomic control. Both acute and chronic hypoxia create alterations in ventilation and blood pressure via catecholamine release, although the mechanisms of these alterations are unknown. The enzymes tyrosine hydroxylase (TH) and phenylethanolamine N-methyltransferase (PNMT) catalyze the rate-limiting step in the catecholamine pathway and production of epinephrine, respectively. Both have been colocalized with Fos protein in metabolic mapping studies of the O2-chemosensory pathway of adult and early postnatal rat. Thus, catecholamines are putative neurotransmitters in a subset of second and higher order respiratory neurons. To characterize the effects of prenatal hypoxia on subsequent TH and PNMT gene and protein expression, pregnant rats were placed in moderate hypoxia (10% O2) from gestational d 18 until birth. Northern and Western analyses of dorsal (catecholaminergic/adrenergic cell group 2) and ventral (catecholaminergic/adrenergic cell group 1) medullary tissue of postnatal (P) age P0, P3, P7, P10, and P14 pups were then done to examine changes in TH and PNMT mRNA and protein compared with normoxia-reared controls. Compared with controls, pups exposed to maternal hypoxia during pregnancy had lower levels of TH mRNA and protein at birth in dorsal medulla and higher levels of TH mRNA the first postnatal week in the ventral medulla. Pups that had been hypoxic in utero showed significantly lower levels of PNMT protein during the second postnatal week in dorsal medulla than did controls. Prenatal hypoxia-induced changes in levels of enzymes responsible for catecholamine synthesis may later be manifest as developmental deficiencies in neuronal function. This may compromise responses to acute hypoxic challenges during early postnatal life and contribute to autonomic nervous system disorders of the newborn such as apnea and sudden infant death syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9380436     DOI: 10.1203/00006450-199710000-00006

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Prenatal hypoxia in rats increased blood pressure and sympathetic drive of the adult offspring.

Authors:  Pavel Svitok; Lubos Molcan; Katarina Stebelova; Anna Vesela; Natalia Sedlackova; Eduard Ujhazy; Mojmir Mach; Michal Zeman
Journal:  Hypertens Res       Date:  2016-02-25       Impact factor: 3.872

2.  Urinary gas chromatography mass spectrometry metabolomics in asphyxiated newborns undergoing hypothermia: from the birth to the first month of life.

Authors:  Antonio Noto; Giulia Pomero; Michele Mussap; Luigi Barberini; Claudia Fattuoni; Francesco Palmas; Cristina Dalmazzo; Antonio Delogu; Angelica Dessì; Vassilios Fanos; Paolo Gancia
Journal:  Ann Transl Med       Date:  2016-11

3.  The effect of fetal hypoxia on adrenocortical function in the 7-day-old rat.

Authors:  H Raff; E D Bruder; B M Jankowski; W C Engeland
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.633

4.  Erythropoietin regulates hypoxic ventilation in mice by interacting with brainstem and carotid bodies.

Authors:  Jorge Soliz; Vincent Joseph; Christophe Soulage; Csilla Becskei; Johannes Vogel; Jean Marc Pequignot; Omolara Ogunshola; Max Gassmann
Journal:  J Physiol       Date:  2005-07-28       Impact factor: 5.182

5.  Prenatal hypoxia impairs the postnatal development of neural and functional chemoafferent pathway in rat.

Authors:  J Peyronnet; J C Roux; A Geloën; L Q Tang; J M Pequignot; H Lagercrantz; Y Dalmaz
Journal:  J Physiol       Date:  2000-04-15       Impact factor: 5.182

Review 6.  Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration.

Authors:  Natalia N Nalivaeva; Anthony J Turner; Igor A Zhuravin
Journal:  Front Neurosci       Date:  2018-11-19       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.